| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/22/2015 | WO2015008229A1 Autotaxin inhibitors |
| 01/22/2015 | WO2015008202A1 Indole-3-carbinol derivatives |
| 01/22/2015 | WO2015007869A1 Local anesthetics and use thereof in cancer |
| 01/22/2015 | WO2015007249A1 N-alkyl tryptanthrin derivative, preparation method for same, and application thereof |
| 01/22/2015 | WO2015007219A1 Quinazoline derivatives, compositions thereof, and use as pharmaceuticals |
| 01/22/2015 | WO2015007206A1 Afatinib acid addition salts and crystal forms thereof, preparation method and pharmaceutical composition thereof |
| 01/22/2015 | US20150024484 Antibody Inhibitors of GDF-8 and Uses Thereof |
| 01/22/2015 | US20150023982 Methods of administering anti-tnfalpha antibodies |
| 01/22/2015 | DE19547958B4 Anthracyclin-Derivate Anthracycline derivatives |
| 01/21/2015 | EP2826790A1 Gremlin-1 antibody |
| 01/21/2015 | EP2826780A1 Thieno[2,3-d]pyridazine derivatives and therapeutic use thereof for protein kinase inhibition |
| 01/21/2015 | EP2826482A1 Novel antitumor agent comprising combination of three agents |
| 01/21/2015 | EP2826480A1 Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesis |
| 01/21/2015 | EP2826474A1 Use of substituted diphenylamine compounds in preparing anti-tumour drugs |
| 01/21/2015 | EP2825693A1 Methods and materials for treating cancer |
| 01/21/2015 | EP2825670A1 Methods of predicting clinical outcome of chronic lymphocytic leukemia |
| 01/21/2015 | EP2825649A1 Selective cell targeting using adenovirus and chemical dimers |
| 01/21/2015 | EP2825562A1 Method to prevent cancer metastasis and inhibit inflammation by inhibition of p68 interaction with calmodulin |
| 01/21/2015 | EP2825549A1 Engineered conformationally-stabilized proteins |
| 01/21/2015 | EP2825540A1 Substituted imidazopyridazines |
| 01/21/2015 | EP2825537A1 Dihydropyridopyrimidine and dihydronaphthyridine derivatives as tyrosine kinase inhibitors of especially vegf and pdgf |
| 01/21/2015 | EP2825528A1 Substituted pyrrolidine-2-carboxamides |
| 01/21/2015 | EP2825201A1 The filamentous bacteriophage as an angiogenesis modulator |
| 01/21/2015 | EP2825197A1 Novel binding molecules with antitumoral activity |
| 01/21/2015 | EP2825189A1 A negative modulator of hedgehog signalling for use in treating th2 -mediated diseases |
| 01/21/2015 | EP2825170A1 Treatment of cancer with tor kinase inhibitors |
| 01/21/2015 | EP2825169A1 Treatment of cancer with tor kinase inhibitors |
| 01/21/2015 | EP2825168A1 Treatment of cancer with tor kinase inhibitors |
| 01/21/2015 | EP2825162A1 Compounds and methods for treating leukemia |
| 01/21/2015 | EP2825161A1 Inhibitors of human ezh2, and methods of use thereof |
| 01/21/2015 | EP2825158A1 Cationic liposomal drug delivery system for specific targeting of human cd14+ monocytes in whole blood |
| 01/21/2015 | CN204111715U 食用油重复使用处理装置 Edible reuse processing apparatus |
| 01/21/2015 | CN104302669A 抗cd98抗体及其使用方法 Antibodies and methods of using the anti-cd98 |
| 01/21/2015 | CN104302657A 免疫调节胜肽用于治疗或预防发炎相关疾病的方法 Immunomodulatory peptides methods for treating or preventing inflammation-related diseases |
| 01/21/2015 | CN104302655A 甾醇衍生物和及其用于治疗牵涉转化的星形胶质细胞的疾病或治疗恶性血液病的用途 Sterol derivatives and their use for the treatment involves the conversion of astrocytes disease or therapeutic purposes hematologic malignancies |
| 01/21/2015 | CN104302648A 琥珀酸盐的晶形 Succinate crystal form |
| 01/21/2015 | CN104302647A 新型吡啶并嘧啶衍生物及其用途 Novel pyridine and pyrimidine derivatives and their use |
| 01/21/2015 | CN104302646A 可用作Raf激酶抑制剂的2-氨基, 6-苯基取代的吡啶并[2,3-d]嘧啶衍生物 Raf kinase inhibitors may be used as 2-amino-6-phenyl-substituted pyrido [2,3-d] pyrimidine derivatives |
| 01/21/2015 | CN104302641A 单环杂芳基环烷基二胺衍生物 Monocyclic heteroaryl cycloalkyl diamine derivative |
| 01/21/2015 | CN104302638A 用于抑制abl1、abl2和bcr-abl1的活性的苯甲酰胺衍生物 For inhibiting abl1, abl2 and bcr-abl1 activity benzamide derivatives |
| 01/21/2015 | CN104302635A 5-[[4-[[吗啉-2-基]甲基氨基]-5-(三氟甲基)-2-吡啶基]氨基]吡嗪-2-腈及其治疗应用 5 - [[4 - [[morpholin-2-yl] methylamino] -5- (trifluoromethyl) -2-pyridinyl] amino] pyrazine-2-carbonitrile and its therapeutic use |
| 01/21/2015 | CN104302628A 羧酸化合物 Carboxylic acid compound |
| 01/21/2015 | CN104302627A 用于治疗癌症的嘧啶化合物 Pyrimidine compounds for the treatment of cancer |
| 01/21/2015 | CN104302620A 内酰胺的合成 Lactam synthesis |
| 01/21/2015 | CN104302358A 3-芳基-5-取代的异喹啉-1-酮化合物和它们的治疗用途 3-aryl-5-substituted isoquinolin-1-one compounds and their therapeutic use |
| 01/21/2015 | CN104302324A 靶向cd138的免疫偶联物的用途 Targeting cd138 use of immunoconjugates |
| 01/21/2015 | CN104302322A 骨·软组织中产生的巨细胞性肿瘤或软骨肉瘤的预防或治疗剂 Bone-soft tissue produced in giant cell tumor or chondrosarcoma prophylactic or therapeutic agent |
| 01/21/2015 | CN104302295A 用tor 激酶抑制剂治疗癌症 Tor kinase inhibitor used to treat cancer |
| 01/21/2015 | CN104302294A 用于治疗淋巴组织增生性恶性肿瘤的作为磷脂酰肌醇3-激酶抑制剂的n-(3-{[(3-{[2-氯-5-(甲氧基)苯基]氨基}喹喔啉-2-基)氨基]磺酰基}苯基)-2-甲基丙氨酰胺 For the treatment of lymphoproliferative malignancies as phosphatidylinositol 3-kinase inhibitor n- (3 - {[(3 - {[2- chloro-5- (methoxy) phenyl] amino} quinolin 2- yl) amino] sulfonyl} phenyl) -2-methyl alaninamide |
| 01/21/2015 | CN104302286A 用于治疗乳腺癌的curaxin和用于鉴别可能响应的患者的方法 A method for the treatment of breast cancer patients and identification of possible responses curaxin for the |
| 01/21/2015 | CN104302278A 在回肠和阑尾上有活性的胃肠位点特异性口服接种疫苗制剂 In the ileum and appendix active gastrointestinal site-specific oral vaccine formulations |
| 01/21/2015 | CN104293921A 一种用于肺癌治疗的磁性纳米复合物及其制备方法 Magnetic nanocomposite and its preparation method for the treatment of lung cancer |
| 01/21/2015 | CN104293857A 一种制备杏鲍菇低分子量多糖的方法 A method of preparing Pleurotus low molecular weight polysaccharides |
| 01/21/2015 | CN104293830A 一种含amiRNA-HIF-1α序列的重组质粒的制备方法及用途 Containing recombinant plasmids amiRNA-HIF-1α sequence preparation and use |
| 01/21/2015 | CN104293815A 一种纳米基因疫苗及其制备方法和应用 A vaccine preparation method and application of gene nano |
| 01/21/2015 | CN104293796A Cacna1e突变基因及其检测方法和应用 Cacna1e mutant gene and its detection methods and applications |
| 01/21/2015 | CN104293791A miR-200b在制备Rac-1蛋白表达抑制剂中的新用途 miR-200b expression inhibitor in the preparation of the new use of Rac-1 protein |
| 01/21/2015 | CN104293789A 抑制S100A8基因表达的siRNA及其应用 S100A8 siRNA inhibition of gene expression and its Applications |
| 01/21/2015 | CN104293788A 抑制S100A9基因表达的siRNA及其应用 S100A9 siRNA inhibition of gene expression and its Applications |
| 01/21/2015 | CN104293787A 一种抑制奶牛EEF1D基因表达的siRNA及其应用 An siRNA its application cows EEF1D suppressor genes |
| 01/21/2015 | CN104293785A microRNA302s在制备抗肿瘤药物中的用途 microRNA302s use in the preparation of anticancer drugs |
| 01/21/2015 | CN104292468A 一种含桦木酸的两性复合物及制备方法和应用 Betulinic acid containing amphoteric compound and preparation method and application |
| 01/21/2015 | CN104292349A 一种制备羧甲基化米糠多糖的设备及方法 Device and method for Carboxymethyl prepared rice bran |
| 01/21/2015 | CN104292334A 一种全人源抗ctla-4单克隆抗体、制备方法及应用 One kind of Human Anti ctla-4 monoclonal antibody preparation method and application |
| 01/21/2015 | CN104292321A 新的半乳凝素9 突变体蛋白质及其用途 The new galectin-9 mutant proteins and their use |
| 01/21/2015 | CN104292308A 新型肿瘤抗原环肽 The new tumor antigen peptide ring |
| 01/21/2015 | CN104292306A 一种多肽alkg及其在治疗白血病药物中的应用 A polypeptide alkg its application in the treatment of leukemia drug |
| 01/21/2015 | CN104292302A 一种增强肿瘤细胞对抗肿瘤药物敏感性的多肽及其应用 An enhanced sensitivity to antineoplastic polypeptide tumor cells and its application |
| 01/21/2015 | CN104292299A 用于表达肿瘤相关抗原的癌症的肽疫苗 Peptide vaccine for the expression of tumor-associated antigens of cancer |
| 01/21/2015 | CN104292290A 以氨基酸为连接子的胆汁酸-药物偶合物及其医药用途 Amino acid linker for bile acid - drug conjugate and medical use |
| 01/21/2015 | CN104292244A 一种6,7-二氢-5H-1,2,4-三唑并[3,4-b][1,3,4]噻二嗪及其制备方法 One kind of 6,7-dihydro -5H-1,2,4- triazolo [3,4-b] [1,3,4] thiadiazine and its preparation method |
| 01/21/2015 | CN104292242A 噻吩嘧啶类化合物和制剂及其制备方法和应用 Thiophene pyrimidine compounds and its preparation method and application |
| 01/21/2015 | CN104292235A 2-(1-正己氧基)乙基二氢卟吩f盐及其药物组合物和用途 2- (1-n-hexyloxy) ethyl chlorin f salts and pharmaceutical compositions and uses |
| 01/21/2015 | CN104292233A 一种吡唑并[1,5-a]嘧啶衍生物及其抗肿瘤用途 One kind of pyrazolo [1,5-a] pyrimidine derivatives and their use of anti-tumor |
| 01/21/2015 | CN104292229A 2-苯氧基嘧啶酮类似物 2-phenoxy pyrimidinone analogues |
| 01/21/2015 | CN104292227A 一种氮杂吖啶芳香环衍生物及其制备方法与应用 One kind of aromatic ring aza acridine derivative and its preparation method and application |
| 01/21/2015 | CN104292225A 取代邻氨基苯甲酸小檗碱盐制备方法及用途 Substituted anthranilic acid salt preparation method and use of berberine |
| 01/21/2015 | CN104292219A 1-(苯并呋喃-5-基)-2-(1,2,4-三唑-1-基)酮肟杂环甲醚及其作为抗癌药的应用 1- (benzofuran-5-yl) -2- (1,2,4-triazol-1-yl) oxime ether heterocycles and their use as anticancer agents |
| 01/21/2015 | CN104292211A 地氯雷他定类一氧化氮供体及其制备方法和用途 Desloratadine class nitric oxide donor and its preparation and use |
| 01/21/2015 | CN104292210A 含吡啶的一氧化氮供体类化合物、其制备方法及用途 Nitric oxide donor compounds containing pyridine and its preparation method and use |
| 01/21/2015 | CN104292186A 粗根大戟中分离的大环二萜类化合物及多药耐药逆转用途 Euphorbia coarse roots isolated macrocyclic diterpenoids and multidrug resistance reversal purposes |
| 01/21/2015 | CN104292171A 3-[4-二-(4-氟苯)甲基哌嗪基]-1,2,4-三氮唑-5-硫酮Schiff碱的合成方法及其应用 3- [4- two - (4-fluorophenyl) methyl-piperazinyl] Synthesis 1,2,4-triazole-5-thione Schiff base and its application |
| 01/21/2015 | CN104292170A 具有抗肿瘤作用的喹唑啉-芳基脲衍生物及其应用 With anti-tumor effect of quinazoline - aryl urea derivatives and its applications |
| 01/21/2015 | CN104292167A 盐酸苯达莫司汀的一氧化氮供体衍生物及其制备方法 Bendamustine hydrochloride nitric oxide donor derivatives and preparation method |
| 01/21/2015 | CN104292163A 具有抗多种肿瘤活性的格尔德霉素类似物及其制备方法和应用 With a variety of anti-tumor activity of geldanamycin analogs and its preparation method and application |
| 01/21/2015 | CN104292140A 含有查尔酮骨架的法尼基硫代水杨酸类似物及制备方法和用途 Containing chalcone skeleton farnesylthiosalicylic acid analogs and preparation and use |
| 01/21/2015 | CN104292139A 法尼基硫醚取代的查尔酮衍生物及制备方法和用途 Farnesyl thioether substituted chalcone derivatives and preparation and use |
| 01/21/2015 | CN104292134A 异羟肟酸类化合物及其制备方法和应用 Hydroxamic acids and its preparation method and application |
| 01/21/2015 | CN104288792A 具有超声造影和光热治疗性能的制剂、其制备方法与应用 Formulations with ultrasound imaging and photothermal therapeutic properties, and its preparation method and application |
| 01/21/2015 | CN104288791A 一种携带Notch-1 shRNA的靶向磁性荧光纳米载体及其制备方法和应用 A portable Notch-1 shRNA targeted fluorescent magnetic nanocarrier its preparation method and application |
| 01/21/2015 | CN104288790A 一种细胞核靶向放疗增敏剂及其制备方法 A nuclear-targeted radiation sensitizers and its preparation method |
| 01/21/2015 | CN104288786A 基于近红外量子点的肿瘤靶向诊疗系统及其制备方法 Diagnoses based tumor targeting and preparation method of near-infrared quantum dots |
| 01/21/2015 | CN104288784A 纳米羟基磷灰石-基因-药物复合物及制备方法和应用 Nano-hydroxyapatite - gene - drug complexes and preparation method and application |
| 01/21/2015 | CN104288779A 负载吉西他滨的peg化肽类树状大分子靶向给药系统及其制备方法 Load gemcitabine peg of peptide dendrimers targeted drug delivery system and its preparation method |
| 01/21/2015 | CN104288778A 一种改善多西紫杉醇亲水性的方法 A docetaxel method of improving hydrophilicity |
| 01/21/2015 | CN104288776A 一种自组装多肽—凋亡素基因复合纳米颗粒及其制备方法和应用 A self-assembling peptide - apoptin gene composite nanoparticles and its preparation method and application |
| 01/21/2015 | CN104288765A 一种利用具有中和FLT3生物学活性的McAb应用于肿瘤的靶向治疗的新方法 A new method has the advantage of McAb and biological activity of FLT3 in cancer targeted therapy |
| 01/21/2015 | CN104288763A 宫颈癌疫苗 Cervical Cancer Vaccine |
| 01/21/2015 | CN104288758A 聚乙二醇化磷脂为载体的胶束多肽疫苗 PEGylated phospholipid micelle carrier peptide vaccine |
| 01/21/2015 | CN104288752A Mdc1在抑制前列腺癌方面的应用 Mdc1 application in terms of suppression of prostate cancer |